Detalhe da pesquisa
1.
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer.
Br J Cancer;
122(3): 361-371, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31772325
2.
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
BMC Cancer;
19(1): 351, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30975104